We are live on ! Find out more
CVS icon

CVS Health

1,815 hedge funds and large institutions have $58.2B invested in CVS Health in 2020 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 828 increasing their positions, 709 reducing their positions, and 144 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $1.81B | Put options by funds: $1.16B

17% more repeat investments, than reductions

Existing positions increased: 828 | Existing positions reduced: 709

1.84% less ownership

Funds ownership: 78.06%76.22% (-1.8%)

3% less funds holding

Funds holding: 1,8631,815 (-48)

12% less capital invested

Capital invested by funds: $66.1B → $58.2B (-$7.97B)

21% less first-time investments, than exits

New positions opened: 114 | Existing positions closed: 144

45% less funds holding in top 10

Funds holding in top 10: 8446 (-38)

Holders
1,815
Holders Change
-48
Holders Change %
-2.58%
% of All Funds
36.62%
Holding in Top 10
46
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-45.24%
% of All Funds
0.93%
New
114
Increased
828
Reduced
709
Closed
144
Calls
$1.81B
Puts
$1.16B
Net Calls
+$646M
Net Calls Change
-$38.2M
Name Holding Trade Value Shares
Change
Change in
Stake
MC
476
Miramar Capital
Illinois
$5.82M +$226K +3,635 +4%
CANC
477
Culbertson A N & Co
Virginia
$5.77M +$93.3K +1,500 +2%
TIM
478
Thompson Investment Management
Wisconsin
$5.76M +$256K +4,112 +4%
CTC
479
Central Trust Company
Missouri
$5.73M -$114K -1,838 -2%
NRS
480
Neville Rodie & Shaw
New York
$5.71M -$1.23M -19,725 -17%
TW
481
TrinityPoint Wealth
Connecticut
$5.7M +$111K +1,778 +2%
SSA
482
Schonfeld Strategic Advisors
New York
$5.68M -$4.78M -76,765 -44%
NC
483
Nicholas Company
Wisconsin
$5.63M +$1.47M +23,565 +32%
BBVA
484
Banco Bilbao Vizcaya Argentaria
Spain
$5.63M +$1.46M +23,428 +32%
GCMG
485
Gyroscope Capital Management Group
Florida
$5.6M -$45K -724 -0.7%
AAM
486
Auxier Asset Management
Oregon
$5.56M +$142K +2,286 +2%
TAF
487
Tredje AP-fonden
Sweden
$5.54M
SG Americas Securities
488
SG Americas Securities
New York
$5.51M +$2.27M +36,535 +63%
CA
489
Cornerstone Advisors
North Carolina
$5.49M +$5.85M +94,000 New
Carson Wealth (CWM LLC)
490
Carson Wealth (CWM LLC)
Nebraska
$5.46M
DILIC
491
Dai-ichi Life Insurance Company
Japan
$5.46M -$2.93M -47,158 -34%
Qube Research & Technologies (QRT)
492
Qube Research & Technologies (QRT)
United Kingdom
$5.44M +$5.8M +93,226 New
LDB
493
Lee, Danner & Bass
Tennessee
$5.41M +$871 +14 +0%
AWM
494
AE Wealth Management
Kansas
$5.41M +$304K +4,881 +6%
AHC
495
Adell Harriman & Carpenter
Texas
$5.41M +$712K +11,447 +14%
AAA
496
Adams Asset Advisors
Texas
$5.38M +$808K +12,983 +16%
CSPIA
497
Cary Street Partners Investment Advisory
Virginia
$5.38M +$5.73M +92,048 New
QOP
498
Quinn Opportunity Partners
Virginia
$5.37M +$1.28M +20,500 +29%
LOAMU
499
Lombard Odier Asset Management (USA)
New York
$5.37M +$2.36M +38,000 +70%
Mercer Global Advisors
500
Mercer Global Advisors
Colorado
$5.37M +$67.5K +1,085 +1%

CVS Hedge Fund Activity: Q3 2020 in Review

1,815 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2020, worth a combined $58.2B — down 12% from $66.1B a quarter earlier.

Sellers outnumbered buyers: 144 funds closed out of CVS and 114 opened new positions — a net loss of 30 holders — while 709 trimmed existing stakes and 828 added.

The largest buyer was Capital World Investors, adding an estimated $408M. The largest seller was Capital International Investors, cutting an estimated $708M.

  • 1,815 institutional investors held CVS Health (CVS) as of Q3 2020, down from 1,863 in Q2 2020.
  • Funds reported $58.2B of CVS Health stock for Q3 2020, down 12% quarter-over-quarter.
  • 114 funds opened new CVS Health positions in Q3 2020 and 144 closed out, a net change of -30 holders.
  • The largest CVS Health buyer in Q3 2020 was Capital World Investors, an estimated $408M added.
  • The largest CVS Health seller in Q3 2020 was Capital International Investors, an estimated $708M sold.

Based on aggregated 13F filings for Q3 2020.